Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Mycobacterium malmoense
Introduction
Overview
Overview
Mycobacterium malmoense is a bacteria. Etymology: malmoense, from the city of Malmö, Sweden where it was first isolated.
Description
Description
Gram-positive, nonmotile, acid-fast and coccoid to short rods.
- Environmental reservoir: soil and water.
Colony characteristics
- Smooth and nonpigmented colonies, growth below the surface of semisolid agar medium after deep inoculation (as seen with M. bovis), 0.9 – 1.7mm in diameter.
Physiology
- Growth on inspissated egg medium and oleic acid-albumin agar at a temperature range of 22°C-37°C requires over 1 week.
- Susceptible to ethambutol, ethionamide, kanamycin and cycloserine.
Differential characteristics
- Antigenic structure: seroagglutination demonstrates a single serovar distinct from that of other species.
Pathogenesis
Pathogenesis
- Usually infects young children with cervical lymphadenitis or adults with chronic pulmonary disease, (mostly with previously documented pneumoconiosis).
- Rarely causes extrapulmonary diseases and disseminated infections
- Biosafety level 2
Type Strain
Type Strain
Strain ATCC 29571 = CCUG 37761 = CIP 105775 = DSM 44163 = JCM 13391 = NCTC 11298.
Treatment
Treatment
Antimicrobial regimen
- 1. In vitro
- Susceptible: Ethambutol, Ethionamide, Kanamycin, and Cycloserine
- Resistant: INH, Streptomycin, Rifampin, and Capreomycin
- 2. Pulmonary M. malmoense infection
- Preferred regimen: INH AND Rifampin AND Ethambutol ± Quinolones AND Macrolides
References
References
- ↑ Griffith, David E.; Aksamit, Timothy; Brown-Elliott, Barbara A.; Catanzaro, Antonino; Daley, Charles; Gordin, Fred; Holland, Steven M.; Horsburgh, Robert; Huitt, Gwen; Iademarco, Michael F.; Iseman, Michael; Olivier, Kenneth; Ruoss, Stephen; von Reyn, C. Fordham; Wallace, Richard J.; Winthrop, Kevin; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007-02-15). “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases”. American Journal of Respiratory and Critical Care Medicine. 175 (4): 367–416. doi:10.1164/rccm.200604-571ST. ISSN 1073-449X. PMID 17277290.
- Schroder,K., I. Juhlin 1977. Mycobacterium malmoense sp. nov. International Journal of Systematic Bacteriology, 1977, 27, 241-246.]
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]